These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23719501)

  • 21. Serum sclerostin levels decline in post-menopausal women with osteoporosis following treatment with intermittent parathyroid hormone.
    Piemonte S; Romagnoli E; Bratengeier C; Woloszczuk W; Tancredi A; Pepe J; Cipriani C; Minisola S
    J Endocrinol Invest; 2012 Oct; 35(9):866-8. PubMed ID: 22842667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased serum sclerostin levels in patients with primary hyperparathyroidism: a cross-sectional and a longitudinal study.
    Ardawi MS; Al-Sibiany AM; Bakhsh TM; Rouzi AA; Qari MH
    Osteoporos Int; 2012 Jun; 23(6):1789-97. PubMed ID: 22041864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating sclerostin in disorders of parathyroid gland function.
    Costa AG; Cremers S; Rubin MR; McMahon DJ; Sliney J; Lazaretti-Castro M; Silverberg SJ; Bilezikian JP
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3804-10. PubMed ID: 21937621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.
    Kim JY; Lee SK; Jo KJ; Song DY; Lim DM; Park KY; Bonewald LF; Kim BJ
    Life Sci; 2013 Mar; 92(10):533-40. PubMed ID: 23357248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased Circulating Sclerostin Levels in Renal Transplant Recipients With Persistent Hyperparathyroidism.
    Evenepoel P; Claes K; Viaene L; Bammens B; Meijers B; Naesens M; Sprangers B; Kuypers D
    Transplantation; 2016 Oct; 100(10):2188-93. PubMed ID: 27379556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and biological determinants of sclerostin plasma concentration in hemodialysis patients.
    Delanaye P; Krzesinski JM; Warling X; Moonen M; Smelten N; Médart L; Bruyère O; Reginster JY; Pottel H; Cavalier E
    Nephron Clin Pract; 2014; 128(1-2):127-34. PubMed ID: 25377055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin.
    Gatti D; Viapiana O; Adami S; Idolazzi L; Fracassi E; Rossini M
    Bone; 2012 Mar; 50(3):739-42. PubMed ID: 22178539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating sclerostin in children and young adults with heritable bone disorders.
    Palomo T; Glorieux FH; Rauch F
    J Clin Endocrinol Metab; 2014 May; 99(5):E920-5. PubMed ID: 24512494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sclerostin and DKK1 in postmenopausal osteoporosis treated with denosumab.
    Gatti D; Viapiana O; Fracassi E; Idolazzi L; Dartizio C; Povino MR; Adami S; Rossini M
    J Bone Miner Res; 2012 Nov; 27(11):2259-63. PubMed ID: 22692843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum sclerostin level might be a potential biomarker for arterial stiffness in prevalent hemodialysis patients.
    Jin S; Zhu M; Yan J; Fang Y; Lu R; Zhang W; Zhang Q; Lu J; Qi C; Shao X; Zhang H; Jiang R; Ni Z
    Biomark Med; 2016 Jul; 10(7):689-99. PubMed ID: 27347702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum sclerostin increases in healthy adult men during bed rest.
    Spatz JM; Fields EE; Yu EW; Divieti Pajevic P; Bouxsein ML; Sibonga JD; Zwart SR; Smith SM
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1736-40. PubMed ID: 22767636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating TGF-β1 levels are negatively correlated with sclerostin levels in early postmenopausal women.
    Cheng Q; Tang W; Sheu TJ; Du Y; Gan J; Li H; Hong W; Zhu X; Xue S; Zhang X
    Clin Chim Acta; 2016 Apr; 455():87-92. PubMed ID: 26826396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow plasma macrophage inflammatory protein protein-1 alpha(MIP-1 alpha) and sclerostin in multiple myeloma: relationship with bone disease and clinical characteristics.
    Wang XT; He YC; Zhou SY; Jiang JZ; Huang YM; Liang YZ; Lai YR
    Leuk Res; 2014 May; 38(5):525-31. PubMed ID: 24656650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between postmenopausal women's sclerostin levels and their bone density, age, body mass index, hormonal status, and smoking and consumption of coffee and dairy products.
    Kalem MN; Kalem Z; Akgun N; Bakırarar B
    Arch Gynecol Obstet; 2017 Mar; 295(3):785-793. PubMed ID: 28138749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women.
    Drake MT; Srinivasan B; Mödder UI; Peterson JM; McCready LK; Riggs BL; Dwyer D; Stolina M; Kostenuik P; Khosla S
    J Clin Endocrinol Metab; 2010 Nov; 95(11):5056-62. PubMed ID: 20631014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting sclerostin as potential treatment of osteoporosis.
    Papapoulos SE
    Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i119-22. PubMed ID: 21339215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased serum sclerostin in postoperative biliary atresia.
    Honsawek S; Udomsinprasert W; Chaiwatanarat T; Vejchapipat P; Chongsrisawat V; Poovorawan Y
    Clin Chim Acta; 2015 Mar; 442():136-40. PubMed ID: 25659290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levels of serum sclerostin, FGF-23, and intact parathyroid hormone in postmenopausal women treated with calcitriol.
    Cheng Q; Wu X; Du Y; Hong W; Tang W; Li H; Chen M; Zheng S
    Clin Interv Aging; 2018; 13():2367-2374. PubMed ID: 30532527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum Sclerostin Level Among Egyptian Rheumatoid Arthritis Patients: Relation to Disease Activity, Bone Mineral Density and Radiological Grading.
    Mehaney DA; Eissa M; Anwar S; Fakhr El-Din S
    Acta Reumatol Port; 2015; 40(3):268-74. PubMed ID: 26535777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.